Procalcitonin to guide antibiotic therapy in the ICU

被引:59
作者
Brechot, Nicolas [1 ,2 ]
Hekimian, Guillaume [1 ,3 ]
Chastre, Jean [1 ,3 ]
Luyt, Charles-Edouard [1 ,3 ]
机构
[1] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Serv Reanimat Med,Inst Cardiol, F-75651 Paris 13, France
[2] Coll France, Ctr Interdisciplinaire Rech Biol, U1050, INSERM, F-75231 Paris 05, France
[3] Univ Paris 06, Hop Pitie Salpetriere, AP HP, INSERM,UMRS 1166,Inst Cardiometab & Nutr iCAN, F-75651 Paris 13, France
关键词
Procalcitonin; Antibiotic stewardship; Nosocomial infection; Sepsis; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; VENTILATOR-ASSOCIATED PNEUMONIA; SYSTEMIC INFLAMMATORY RESPONSE; C-REACTIVE PROTEIN; CALCITONIN-I GENE; SERUM PROCALCITONIN; PLASMA-CONCENTRATIONS; PROGNOSTIC MARKER; ELIMINATION RATE;
D O I
10.1016/j.ijantimicag.2015.10.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The serum procalcitonin (PCT) concentration reflects both the systemic response to bacterial infection and its severity. However, its accuracy in distinguishing intensive care unit (ICU) patients with and without infection remains low owing to a lack of specificity and the time lapse between infection onset and the PCT rise. Hence, PCT cannot be used as a marker to start or withhold antibiotic therapy for ICU patients. However, the kinetics of the PCT concentration decrease under antibiotic therapy can adequately monitor infection evolution with therapy and can help to customise antibiotic duration. PCT-guided algorithms to guide antibiotic discontinuation were able to shorten antibiotic duration without impacting patient outcomes in several multicentre randomised studies. Notably, antibiotics can be stopped very early when PCT is low and remains low as this indicates that bacterial infection is unlikely. When PCT falls to <0.5 ng/mL or >80% from its peak value, antibiotics for non-localised infections can safely be stopped. (C) 2015 The Authors. Published by Elsevier B.V.
引用
收藏
页码:S19 / S24
页数:6
相关论文
共 56 条
[1]   Procalcitonin after cardiac arrest - An indicator of severity of illness, ischemia-reperfusion injury and outcome [J].
Annborn, Martin ;
Dankiewicz, Josef ;
Erlinge, David ;
Hertel, Sabine ;
Rundgren, Malin ;
Smith, J. Gustav ;
Struck, Joachim ;
Friberg, Hans .
RESUSCITATION, 2013, 84 (06) :782-787
[2]   Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients [J].
Aouifi, A ;
Piriou, V ;
Bastien, O ;
Blanc, P ;
Bouvier, H ;
Evans, R ;
Célard, M ;
Vandenesch, F ;
Rousson, R ;
Lehot, JJ .
CRITICAL CARE MEDICINE, 2000, 28 (09) :3171-3176
[3]   Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients [J].
Assink-de Jong, Evelien ;
de lange, Dylan W. ;
van Oers, Jos A. ;
Nijsten, Maarten W. ;
Twisk, Jos W. ;
Beishuizen, Albertus .
BMC INFECTIOUS DISEASES, 2013, 13
[4]   Clinical review 167 -: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis:: A journey from calcitonin back to its precursors [J].
Becker, KL ;
Nylén, ES ;
White, JC ;
Müller, B ;
Snider, RH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1512-1525
[5]   Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients [J].
Bele, Nicolas ;
Darmon, Michael ;
Coquet, Isaline ;
Feugeas, Jean-Paul ;
Legriel, Stephane ;
Adaoui, Nadir ;
Schlemmer, Benoit ;
Azoulay, Elie .
BMC INFECTIOUS DISEASES, 2011, 11
[6]   Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial [J].
Bouadma, Lila ;
Luyt, Charles-Edouard ;
Tubach, Florence ;
Cracco, Christophe ;
Alvarez, Antonio ;
Schwebel, Carole ;
Schortgen, Frederique ;
Lasocki, Sigismond ;
Veber, Benoit ;
Dehoux, Monique ;
Bernard, Maguy ;
Pasquet, Blandine ;
Regnier, Bernard ;
Brun-Buisson, Christian ;
Chastre, Jean ;
Wolff, Michel .
LANCET, 2010, 375 (9713) :463-474
[7]   Systemic Inflammatory Response and Potential Prognostic Implications After Out-of-Hospital Cardiac Arrest: A Substudy of the Target Temperature Management Trial [J].
Bro-Jeppesen, John ;
Kjaergaard, Jesper ;
Wanscher, Michael ;
Nielsen, Niklas ;
Friberg, Hans ;
Bjerre, Mette ;
Hassager, Christian .
CRITICAL CARE MEDICINE, 2015, 43 (06) :1223-1232
[8]   Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury [J].
Carsin, H ;
Assicot, M ;
Feger, F ;
Roy, O ;
Pennacino, I ;
LeBever, H ;
Ainaud, P ;
Bohuon, C .
BURNS, 1997, 23 (03) :218-224
[9]   Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report [J].
Charles, Pierre Emmanuel ;
Kus, Emmanuel ;
Aho, Serge ;
Prin, Sebastien ;
Doise, Jean-Marc ;
Olsson, Nils-Olivier ;
Blettery, Bernard ;
Quenot, Jean-Pierre .
BMC INFECTIOUS DISEASES, 2009, 9
[10]   Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial [J].
Chastre, J ;
Wolff, M ;
Fagon, JY ;
Chevret, S ;
Thomas, F ;
Wermert, D ;
Clementi, E ;
Gonzalez, J ;
Jusserand, D ;
Asfar, P ;
Perrin, D ;
Fieux, F ;
Aubas, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19) :2588-2598